Philadelphia Overdose Deaths by Year
2024: 1,069 deaths (↓18% from 2023) | 2023: 1,310 deaths (↓7% from 2022) | 2022: 1,413 deaths (highest on record) | 2021: 1,276 deaths. Sources: PDPH 2024 report, PDPH 2023 report, City of Philadelphia (2021 count). All figures are unintentional drug overdose deaths reported by the Philadelphia Department of Public Health.
What Substances Are Involved?
In 2023: fentanyl was involved in 80% of drug-involved overdose deaths, cocaine in 63%, and xylazine ('tranq') in 38%; 15% involved a stimulant without any opioids (PDPH). In 2024: fentanyl was detected in 93% of opioid-involved deaths, xylazine in 34% of all overdose deaths, and medetomidine in 9% (the Medical Examiner began testing for it in May 2024); 20% involved stimulants but no opioids, an 8.6% increase from 2023 (PDPH 2024 report). In the drug supply itself, medetomidine was found in 72% of illegal opioid samples tested in the last four months of 2024 (CDC MMWR). The dominant pattern is poly-drug death: opioids and stimulants were co-detected in half of 2024 overdose deaths.
Which Philadelphia Neighborhoods Have the Highest Overdose Rates?
Overdose deaths occurred in nearly every Philadelphia ZIP code in 2024, and 59% of ZIP codes recorded 10 or more. The most deaths were in 19134 (Kensington, Port Richmond, Harrowgate) with 179, followed by 19124 (82), 19133 (58), 19132 (57) and 19140 (54) (PDPH 2024 report). The crisis is not limited to open-air drug markets: in 2021, 69% of fatal overdoses took place in the victim's home (City of Philadelphia).
Racial Disparities in Philadelphia Overdose Deaths
The declines have not been even. From 2022 to 2023, deaths fell 15% among non-Hispanic White residents and 5% among non-Hispanic Black residents, while deaths among Hispanic residents rose 2%; Black Philadelphians accounted for 47% of 2023 overdose deaths (PDPH 2023 report). In 2024 the pattern shifted: deaths fell 27% among non-Hispanic Black residents, 26% among Hispanic residents and 4% among non-Hispanic White residents. Black residents still accounted for 42% of 2024 deaths, and 70% of people who died of a stimulant-only overdose were non-Hispanic Black (PDPH 2024 report).
Naloxone and Harm Reduction in Philadelphia
The Philadelphia Department of Public Health distributed over 100,000 doses of naloxone in 2023, almost double the 2022 total (PDPH). Prevention Point, a major harm reduction provider, distributes naloxone citywide, and Naloxone Near Me vending machines are installed at multiple locations. Narcan nasal spray has been approved for over-the-counter, nonprescription sale since March 2023 (FDA).
When you're ready, help is available 24/7 — call (215) 792-4574. Free, confidential insurance verification.